Quick Search:

uzh logo
Browse by:

Zurich Open Repository and Archive

Maintenance: Tuesday, July the 26th 2016, 07:00-10:00

ZORA's new graphical user interface will be relaunched (For further infos watch out slideshow ZORA: Neues Look & Feel). There will be short interrupts on ZORA Service between 07:00am and 10:00 am. Please be patient.

Sudano, I; Hermann, M; Ruschitzka, F T (2007). Endothelin-receptor antagonists in arterial hypertension: further indications? Curr Hypertens Rep, 9(1):59-65.

Full text not available from this repository.

View at publisher


Endothelin-1 exerts vasoactive, pro-inflammatory, hypertrophic, and profibrotic properties on the heart, kidney, and blood vessels. Hence, endothelin-receptor antagonists hold the potential to reduce blood pressure and to prevent complications of hypertension, atherosclerosis, and diabetes through blood pressure-independent effects on cardiovascular growth, inflammation, and fibrosis. These potentially important effects of endothelin antagonism may contribute to its therapeutic potential in hypertension and other cardiovascular disorders, including chronic renal failure and diabetes. First clinical trial evidence demonstrates a moderate reduction in blood pressure in studies of patients with mild-to-moderate essential hypertension and patients with resistant hypertension. Future large-scale randomized clinical trials will provide more insight into whether the blood-pressure reduction and promising pleiotropic effects observed with several members of this novel class of drugs, which are already established therapy in pulmonary hypertension, will translate into clinical benefit in patients with arterial hypertension.


5 citations in Web of Science®
4 citations in Scopus®
Google Scholar™


Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Cardiology
Dewey Decimal Classification:610 Medicine & health
Uncontrolled Keywords:Angiotensin II Type 1 Receptor Blockers/therapeutic use;Animals;Antihypertensive Agents/pharmacology/*therapeutic use;Blood Pressure/drug effects;Endothelium, Vascular/drug effects/physiopathology;Humans;Hypertension/*drug therapy/physiopathology;Receptors, Endothelin/*antagonists & inhibitors;Vascular Resistance/drug effects;Vasoconstriction/drug effects
Deposited On:03 Jan 2011 14:32
Last Modified:05 Apr 2016 14:17
Publisher:Current Science, Inc.
Publisher DOI:10.1007/s11906-007-0011-9
PubMed ID:17362673

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page